HCA Healthcare, Inc. (NYSE:HCA) Stock Holdings Lessened by Te Ahumairangi Investment Management Ltd

Te Ahumairangi Investment Management Ltd decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 16.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 21,256 shares of the company's stock after selling 4,089 shares during the period. HCA Healthcare makes up approximately 1.5% of Te Ahumairangi Investment Management Ltd's holdings, making the stock its 17th largest position. Te Ahumairangi Investment Management Ltd's holdings in HCA Healthcare were worth $8,590,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Sequoia Financial Advisors LLC boosted its holdings in shares of HCA Healthcare by 12.5% in the second quarter. Sequoia Financial Advisors LLC now owns 2,446 shares of the company's stock valued at $786,000 after acquiring an additional 272 shares in the last quarter. GPS Wealth Strategies Group LLC raised its stake in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after buying an additional 71 shares in the last quarter. Westside Investment Management Inc. grew its holdings in HCA Healthcare by 14.7% during the second quarter. Westside Investment Management Inc. now owns 289 shares of the company's stock worth $93,000 after acquiring an additional 37 shares during the period. Assenagon Asset Management S.A. lifted its holdings in HCA Healthcare by 251.9% in the second quarter. Assenagon Asset Management S.A. now owns 39,660 shares of the company's stock valued at $12,742,000 after acquiring an additional 28,389 shares during the period. Finally, Blue Trust Inc. increased its holdings in shares of HCA Healthcare by 0.6% in the 2nd quarter. Blue Trust Inc. now owns 40,252 shares of the company's stock valued at $13,425,000 after purchasing an additional 230 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Down 1.0 %

HCA stock traded down $3.15 during midday trading on Thursday, reaching $311.99. 1,542,021 shares of the company's stock traded hands, compared to its average volume of 1,203,409. The business has a 50-day moving average price of $358.55 and a two-hundred day moving average price of $358.60. HCA Healthcare, Inc. has a fifty-two week low of $261.31 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company has a market capitalization of $79.03 billion, a P/E ratio of 14.15, a PEG ratio of 1.23 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare's dividend payout ratio (DPR) is currently 11.85%.

Insiders Place Their Bets

In related news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on HCA shares. Raymond James cut shares of HCA Healthcare from an "outperform" rating to a "market perform" rating in a report on Friday, November 22nd. Oppenheimer boosted their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Wells Fargo & Company downgraded HCA Healthcare from an "equal weight" rating to an "underweight" rating and cut their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a report on Monday, October 28th. Finally, UBS Group boosted their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a "buy" rating in a report on Wednesday, August 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $387.13.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.